Citation Impact
Citing Papers
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
Neutrophils Suppress Intraluminal NK Cell–Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells
2016
Neutrophils Promote Liver Metastasis via Mac-1–Mediated Interactions with Circulating Tumor Cells
2012
Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
2013
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
2011
Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablation
2012
DNA methylation arrays as surrogate measures of cell mixture distribution
2012 Standout
A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study
2011
Blood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor
2012
Myeloid-derived suppressor cells coming of age
2018 Standout
Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients
2013
Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer
2012
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
2013
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
2012
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
2010
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Neutrophil‐to‐lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation
2011
Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer
2012
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
2011
Systemic inflammation, nutritional status and survival in patients with cancer
2009
Prognostic Value of Neutrophil-to-lymphocyte Ratio and Establishment of Novel Preoperative Risk Stratification Model in Bladder Cancer Patients Treated With Radical Cystectomy
2012
Coordinated regulation of myeloid cells by tumours
2012 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer
2010
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
2011
Polymorphonuclear granulocytes in human head and neck cancer: Enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease
2010
A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection
2010
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Comparison of Two Inflammation-Based Prognostic Scores in Patients with Unresectable Advanced Gastric Cancer
2012
Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer
2011
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
2013
Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
2012
Neutrophil diversity and plasticity in tumour progression and therapy
2020
The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment
2009
Emerging Biological Principles of Metastasis
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy
2013
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer
2012
Predictive clinical outcome of the intratumoral CD66b‐positive neutrophil‐to‐CD8‐positive T‐cell ratio in patients with resectable nonsmall cell lung cancer
2011
Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy
2012
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
2012
Effect of preoperative neutrophil–lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy
2011
Neutrophils in cancer: neutral no more
2016 Standout
Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?
2012
Cancer-related inflammation and treatment effectiveness
2014 Standout
Blood Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
2011
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
2010
Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma
2012
DNA methylation GrimAge strongly predicts lifespan and healthspan
2019 Standout
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of Recurrence in Patients With Nonmetastatic Renal Cell Carcinoma
2010
Neutrophil extracellular traps sequester circulating tumor cells via β1-integrin mediated interactions
2017
Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma
2011
Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable Cancer
2009
Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer.
2011
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 Standout
Prognostic Significance of Host‐ and Tumor‐Related Factors in Patients with Gastric Cancer
2009
An epigenetic biomarker of aging for lifespan and healthspan
2018 Standout
Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto's thyroiditis
2017
Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma.
2012
Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters
2020 Standout
Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
2012
Works of Kook Lee being referenced
Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
2008